Clinical Trials
246 trialsNCT05100056 2026-05-27
BV-MAZOVIA
Takeda
Recruiting
NCT07602088 2026-05-22
REALITY-RO
Janssen Research & Development, LLC
Recruiting
NCT06714370 2026-05-20
REVEAL
Ono Pharmaceutical Co., Ltd.
Completed
NCT06548152 2026-05-19
AQUALIS
AstraZeneca
Recruiting
NCT06790420 2026-05-15
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Completed
NCT05140369 2026-05-14
CLL registry
AstraZeneca
Active not recruiting
NCT02808780 2026-05-08
OPAL
Janssen Biotech, Inc.
Active not recruiting
NCT06299540 2026-05-08
QOLIBRI
Janssen Cilag S.A.S.
Recruiting
NCT06785818 2026-05-05
Long-term Follow up Local Registry Study of Kymriah in South Korea
Novartis
Recruiting
NCT07200375 2026-05-04
GlofitReal
Hoffmann-La Roche
Recruiting
NCT05954910 2026-05-01
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche
Active not recruiting
NCT06125795 2026-05-01
PROVIDENCE
AbbVie
Active not recruiting
NCT07282548 2026-04-29
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
Ipsen
Withdrawn
NCT06476665 2026-04-28
A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
Pfizer
Active not recruiting
NCT04981795 2026-04-27
realMIND
Incyte Corporation
Completed
NCT05557695 2026-04-23
EPIC
AstraZeneca
Recruiting
NCT06205498 2026-04-23
ARISE
AstraZeneca
Active not recruiting
NCT07288515 2026-04-17
ALICIA(BY)
AstraZeneca
Recruiting
NCT07378969 2026-04-14
Lythesia
Novartis
Recruiting
NCT05481437 2026-04-13
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Takeda
Recruiting
NCT04911478 2026-04-09
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
Adicet Therapeutics
Active not recruiting
NCT06170671 2026-03-23
REACH
AstraZeneca
Active not recruiting
NCT04635384 2026-03-18
ACROBAT
CareDx
Active not recruiting
NCT07474051 2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
NCT05332054 2026-03-12
LTFS
Caribou Biosciences, Inc.
Enrolling by invitation
NCT05999877 2026-03-10
PICAROS
AstraZeneca
Active not recruiting
NCT05640102 2026-03-04
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
BeOne Medicines
Recruiting
NCT07154823 2026-03-03
Aquarius
Tempus AI
Recruiting
NCT05437250 2026-03-02
NAOS
AstraZeneca
Active not recruiting
NCT06830759 2026-02-17
EpcoReal
AbbVie
Recruiting
NCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT06043011 2026-01-28
RUBIN
iOMEDICO AG
Recruiting
NCT06357754 2026-01-22
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Bristol-Myers Squibb
Recruiting
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT05228158 2026-01-02
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
Eisai Inc.
Active not recruiting
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT04837222 2025-12-24
A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
Takeda
Active not recruiting
NCT06985576 2025-12-18
Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
Not yet recruiting
NCT03342144 2025-12-08
VeRVe
AbbVie
Recruiting
NCT04746950 2025-12-08
ALICIA
AstraZeneca
Active not recruiting
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT04178317 2025-12-04
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
AbbVie
Completed
NCT05645172 2025-12-01
RETAIN
AstraZeneca
Active not recruiting
NCT07256015 2025-12-01
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Bristol-Myers Squibb
Recruiting
NCT06362044 2025-11-25
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
AbbVie
Completed
NCT03816683 2025-11-14
SUMMIT
AstraZeneca
Completed
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT07189806 2025-09-24
MAPLE-UK
Hvivo
Recruiting
NCT05326308 2025-09-23
ARIADNE
iOMEDICO AG
Recruiting
NCT06358001 2025-09-22
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Completed